` Comparison: BMRN vs CANF - Alpha Spread

BMRN
vs
C
CANF

Over the past 12 months, BMRN has significantly outperformed CANF, delivering a return of -11% compared to the CANF's 89% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BMRN
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BMRN Intrinsic Value
88.53 USD
Undervaluation 29%
Intrinsic Value
Price
C
CANF Intrinsic Value
5 120.66 ILS
Undervaluation 87%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
63.11 USD
C
Can Fite Biopharma Ltd
TASE:CANF
690 ILS
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BMRN, CANF

BMRN
CANF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Biomarin Pharmaceutical Inc
Revenue
C
Can Fite Biopharma Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BMRN, CANF

BMRN
CANF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
C
Can Fite Biopharma Ltd
TASE:CANF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BMRN
81.3%
CANF
0%

Operating Margin

BMRN
20.2%
CANF
-1 487.2%

Net Margin

BMRN
16.8%
CANF
-1 456.2%

FCF Margin

BMRN
26.7%
CANF
-953.8%

ROE

BMRN
9.1%
CANF
-382.9%

ROA

BMRN
7.2%
CANF
-187%

ROIC

BMRN
8.4%
CANF
-6 189.1%

ROCE

BMRN
9.7%
CANF
-273.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BMRN, CANF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BMRN, CANF

Loading
BMRN
CANF
Difference
www.alphaspread.com

Performance By Year
BMRN, CANF

Loading
BMRN
CANF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BMRN to other stocks
EPE
Epizyme Inc
E
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
ATXS
Astria Therapeutics Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account